-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MaWhR5v4HL86IYuciqfOgeoMLUYDXzkFvEHuvqL3ZICozouZJoLvpoPElxbLdzoG j+9awXpIg+RpdeTtVxaIAg== 0001171843-08-000287.txt : 20080423 0001171843-08-000287.hdr.sgml : 20080423 20080423170913 ACCESSION NUMBER: 0001171843-08-000287 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080421 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20080423 DATE AS OF CHANGE: 20080423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BSD MEDICAL CORP CENTRAL INDEX KEY: 0000320174 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 751590407 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32526 FILM NUMBER: 08772372 BUSINESS ADDRESS: STREET 1: 2188 W 2200 SOUTH CITY: SALT LAKE CITY STATE: UT ZIP: 84119 BUSINESS PHONE: 8019725555 MAIL ADDRESS: STREET 1: 2188 WEST STREET 2: 2200 SOUTH CITY: SALT LAKE CITY STATE: UT ZIP: 84119 8-K 1 document.htm FORM 8-K FILING DOCUMENT Form 8-K Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 21, 2008


BSD Medical Corporation
(Exact name of registrant as specified in its charter)


Delaware
 
001-32526
 
75-1590407
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)


 
2188 West 2200 South, Salt Lake City, Utah
 
84119
 
  (Address of principal executive offices)   (Zip Code)  

Registrant's telephone number, including area code:   (801) 972-5555



________________________________________________________________________________
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure.

BSD Medical Corporation issued a press release on April 21, 2008. A copy of the press release is hereby furnished as Exhibit 99.1 attached hereto.

Item 9.01. Financial Statements and Exhibits.

(d)       Exhibits

99.1     Press Release of BSD Medical Corporation dated April 21, 2008


SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    BSD Medical Corporation
(Registrant)

April 21, 2008
(Date)
  /s/   HYRUM A. MEAD
Hyrum A. Mead
President

EXHIBIT INDEX

Exhibit No.       Description

99.1                   Press Release of BSD Medical Corporation dated April 21, 2008

EX-99.1 2 newsrelease.htm PRESS RELEASE BSD Medical to Open Trading On NASDAQ April 22

EXHIBIT 99.1

BSD Medical to Open Trading On NASDAQ April 22

SALT LAKE CITY, April 21, 2008 (PRIME NEWSWIRE) -- BSD Medical Corporation (AMEX:BSM) announced today that it will begin trading on the NASDAQ Stock Market LLC(r) effective Tuesday, April 22, 2008. The company is switching the listing of its common stock from the American Stock Exchange to the NASDAQ stock market, and on April 22 it will open trading under the symbol NASDAQ:BSDM, replacing its former symbol AMEX:BSM.

BSD Medical believes that the electronic multiple market maker structure provided by NASDAQ will enhance the exposure and liquidity of its shares, while at the same time providing investors with the best prices, the fastest execution and lower cost per trade.

The company's objective is also to provide added visibility to its investors. NASDAQ provides the largest liquidity pool, and in 2007 became the largest U.S. stock exchange. NASDAQ is recognized as the home to the world's leading brands, and BSD Medical is pleased to join the NASDAQ Stock Market.

About BSD Medical Corporation

BSD Medical is a leading developer of medical systems used to deliver precision-focused RF or microwave energy for the treatment of cancer and other diseases and conditions. BSD Medical's cancer therapy systems have been designed to kill cancer through heat alone, or as companion therapies to improve the combined results when used along with other treatments. As a biotechnology company, the "BSD" in its name represents the company's specialty in "bio-systems design." For further information visit BSD Medical's website at www.BSDMedical.com.

About NASDAQ

NASDAQ(r) is the largest U.S. electronic stock market. With approximately 3,200 companies, it lists more companies and, on average, its systems trade more shares per day than any other U.S. market. NASDAQ is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology.

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.

CONTACT:  BSD Medical Corporation
          Hyrum A. Mead
          (801) 972-5555
          Fax: (801) 972-5930
          investor@bsdmc.com
-----END PRIVACY-ENHANCED MESSAGE-----